Anthropic announced that Claude, guided by researchers at its San Francisco biology lab, autonomously identified a new enzyme system in bacteriophage DNA that could represent a previously undescribed gene-editing mechanism, with a repeat architecture similar to CRISPR. Anthropic itself is clear on one thing: it still doesn't know what the system actually does.
The system was named ART (array-associated reverse transcriptases). It's made up of three parts: a reverse transcriptase enzyme (which copies RNA into DNA), an associated gene of still-unknown function, and a series of DNA repeats at regular intervals — the same "repeats + enzyme" architecture that characterizes CRISPR, though that doesn't mean ART works the same way. According to Anthropic, the system appears mostly in the genomes of bacteriophages (viruses that infect bacteria).
The process was essentially a massive, systematic search: hundreds of agents reviewing and classifying hundreds of thousands of genomic sequences in parallel — the kind of work that would take a human bioinformatics team far, far longer. It was the scale of the search, not a single flash of intuition, that made it possible to isolate one interesting candidate out of thousands of possibilities.
Carlos Montiel is an enterprise AI solutions architect. He implements LLMs, Agents, RAG and orchestrators for companies across Guatemala and Latin America. Reach out for a consultation.
Contact Carlos Montiel